title: Increasing uptake of Gardasil among American adolescents: comparisons with the history of Hepatitis B vaccination.
abstract: OBJECTIVE
  This paper identifies differences in the uptake rate of Gardasil and contrasts Gardasil uptake rate with the history of Hepatitis B vaccination.
  
  
  METHODS
  A targeted review of peer-reviewed journals and industry commentary was conducted. New trends were calculated and figures created based on secondary data.
  
  
  RESULTS
  The distribution of HPV vaccine does not conform to the geographic incidence rate of cervical cancer. Contrary to contemporary belief, school immunization mandates for Hepatitis B vaccines were not the impetus for their acceptance. Familial beliefs about HPV vaccines appear to be the most significant challenge to Gardasil uptake rate.
  
  
  CONCLUSIONS
  Gardasil is at a critical juncture for increased uptake. Evidence-based educational interventions are needed.
authors.affiliation: Texas A&M Health Science Center, School of Rural Public Health, Department of Health Policy & Management, College Station, TX, USA. dickerson@srph.tamhsc.edu
authors.forename: Justin B
authors.initials: JB
authors.lastname: Dickerson
authors.forename: Matthew Lee
authors.initials: ML
authors.lastname: Smith
authors.forename: Marcia G
authors.initials: MG
authors.lastname: Ory
mesh_terms: D000293:Adolescent; D002675:Child, Preschool; D003365:Costs and Cost Analysis; D017325:Hepatitis B Vaccines / Q000008:administration & dosage* / Q000191:economics; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000191:economics; D014481:United States; D014611:Vaccination / Q000191:economics / Q000706:statistics & numerical data*
chemical_list: D017325:Hepatitis B Vaccines; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines